Acarix launches cardiology device in the first three countries

The Danish medtech company Acarix, which carried out an IPO in Sweden last year, has launched its CADScor System for diagnosing Coronary Artery Disease in the first three countries, including Denmark. At the same time, the workforce has been significantly increased through the establishment of a commercial organization.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Dansk biotekboss rejser 91 mio til at udfordre Novo Nordisk

Et amerikansk biotekselskab, som er grundlagt af en dansk molekylærbiolog, har rejst 91 mio. kr. til at fremme programmer inden for diabetes, fedme og fedtlever, herunder et "transformativt" diabeteslægemiddel rettet mod biologiske mål, som Novo Nordisk også arbejder med.

Related articles